US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 3.5100
  • +0.2400+7.34%
Close Nov 8 16:00 ET
32.39MMarket Cap-557P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SAB Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 333.330K --
-- 2024/Q4 -- / 200.000K --
-- 2024/Q3 -- / 120.000K --
-- 2024/Q2 263.140K / 0.000 --
-- 2024/Q1 944.580K / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 333.330K--
--2024/Q4-- / 200.000K--
--2024/Q3-- / 120.000K--
--2024/Q2263.140K / 0.000--
--2024/Q1944.580K / 0.000--

Unlock Free Earnings Estimates

SAB Biotherapeutics Earnings Reports

  • 10-Q: Quarterly report

    Nov 7 06:08

  • 10-Q: Q2 2024 Earnings Report

    Aug 9 04:37

  • 10-Q: Q1 2024 Earnings Report

    May 21 04:06

  • SAB Biotherapeutics | 10-K: FY2023 Annual Report

    Mar 30 01:23

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data